Comparison of the effect of antiglaucoma drugs with Selective Laser Trabeculoplasty (SLT) in patients with primary open angle glaucoma

Zahedan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2023年10月16日

适应症

试验速览

暂无简介。

•Age more than 18 years
•Diagnosis of POAG (POAG is an optic neuropathy with increased intraocular pressure in which the angle of the anterior chamber of the eye is open and no secondary disease or cause can be found to justify optic nerve damage or increased intraocular pressure).
•Newly diagnosed patients and those who are currently receiving the standard first-line treatment, i.e. latanoprost eye drops, but their target IOP has not been achieved.

•Secondary glaucoma diagnosis
•One eye patients (patients whose other eye is blind for any reason).
•Having very high IOP (above 30 mm Hg)
•Patients who have currently received the maximum tolerated medical treatment (Maximum Tolerated Medical Treatment), but despite the treatment, their IOP has not been controlled.
•History of laser trabeculoplasty or retina surgery
•History of cataract surgery in the last 3 months
•Active eye infection or inflammation
•Narrow eye angle
•Pregnant or lactating women
•Any eye disease that prevents accurate IOP measurement. Like a corneal scar
•Any unstable medical condition that prevents compliance with the scientific and ethical bases of the study protocol.

发起方

Zahedan University of Medical Sciences